232 related articles for article (PubMed ID: 35492003)
1. Age-Related Associations of Low-Density Lipoprotein Cholesterol and Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Cohort Study.
Jung HN; Kim MJ; Kim HS; Lee WJ; Min SH; Kim YJ; Jung CH
J Am Heart Assoc; 2022 May; 11(9):e024637. PubMed ID: 35492003
[TBL] [Abstract][Full Text] [Related]
2. Discordance Between Very Low-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol Increases Cardiovascular Disease Risk in a Geographically Defined Cohort.
Seehusen KE; Remaley AT; Sampson M; Meeusen JW; Larson NB; Decker PA; Killian JM; Takahashi PY; Roger VL; Manemann SM; Lam R; Bielinski SJ
J Am Heart Assoc; 2024 Apr; 13(8):e031878. PubMed ID: 38591325
[TBL] [Abstract][Full Text] [Related]
3. The Association Between Low-Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled Cohorts.
Nanna MG; Navar AM; Wojdyla D; Peterson ED
J Am Geriatr Soc; 2019 Dec; 67(12):2560-2567. PubMed ID: 31411740
[TBL] [Abstract][Full Text] [Related]
4. Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease.
Lin Z; Chen Y; Xiao Z; Xu W; Chen G; Huang C; Feng W; Xie Z; Liao W; Liao Y; Bin J; Feng L; Wang S
Mayo Clin Proc; 2023 Sep; 98(9):1280-1296. PubMed ID: 37661139
[TBL] [Abstract][Full Text] [Related]
5. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
6. Associations of LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B With Cardiovascular Disease Occurrence in Adults: Korean Genome and Epidemiology Study.
Yun SY; Rim JH; Kang H; Lee SG; Lim JB
Ann Lab Med; 2023 May; 43(3):237-243. PubMed ID: 36544335
[TBL] [Abstract][Full Text] [Related]
7. Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events.
Wu F; Juonala M; Jacobs DR; Daniels SR; Kähönen M; Woo JG; Sinaiko AR; Viikari JSA; Bazzano LA; Burns TL; Steinberger J; Urbina EM; Venn AJ; Raitakari OT; Dwyer T; Magnussen CG
Circulation; 2024 Jan; 149(3):217-226. PubMed ID: 38014550
[TBL] [Abstract][Full Text] [Related]
8. Serum Low-Density Lipoprotein Cholesterol and Cardiovascular Disease Risk Across Chronic Kidney Disease Stages (Data from 1.9 Million United States Veterans).
Hashemi L; Hsiung JT; Arif Y; Soohoo M; Jackson N; Gosmanova EO; Budoff M; Kovesdy CP; Kalantar-Zadeh K; Streja E
Am J Cardiol; 2022 May; 170():47-55. PubMed ID: 35300833
[TBL] [Abstract][Full Text] [Related]
9. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
10. Twenty-year epidemiologic study on LDL-C levels in relation to the risks of atherosclerotic event, hemorrhagic stroke, and cancer death among young and middle-aged population in China.
Zhang X; Liu J; Wang M; Qi Y; Sun J; Liu J; Wang Y; Hao Y; Li Y; Zhou M; Zhao D
J Clin Lipidol; 2018; 12(5):1179-1189.e4. PubMed ID: 30037589
[TBL] [Abstract][Full Text] [Related]
11. J-shaped association between LDL cholesterol and cardiovascular events: A longitudinal primary prevention cohort of over 2.4 million people nationwide.
Park CS; Yang HM; Han K; Lee HS; Kang J; Han JK; Park KW; Kang HJ; Koo BK; Kim HS
J Adv Res; 2024 Apr; 58():139-147. PubMed ID: 37225014
[TBL] [Abstract][Full Text] [Related]
12. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study.
Quispe R; Martin SS; Michos ED; Lamba I; Blumenthal RS; Saeed A; Lima J; Puri R; Nomura S; Tsai M; Wilkins J; Ballantyne CM; Nicholls S; Jones SR; Elshazly MB
Eur Heart J; 2021 Nov; 42(42):4324-4332. PubMed ID: 34293083
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein cholesterol response after statin initiation among persons living with human immunodeficiency virus.
Burkholder GA; Muntner P; Zhao H; Mugavero MJ; Overton ET; Kilgore M; Drozd DR; Crane HM; Moore RD; Mathews WC; Geng E; Boswell S; Floris-Moore M; Rosenson RS
J Clin Lipidol; 2018; 12(4):988-998.e5. PubMed ID: 29853312
[TBL] [Abstract][Full Text] [Related]
14. Treatment and Low-Density Lipoprotein Cholesterol Management in Patients Diagnosed With Clinical Atherosclerotic Cardiovascular Disease in Alberta.
Chen G; Farris MS; Cowling T; Colgan SM; Xiang P; Pericleous L; Rogoza RM; Tai MH; Anderson T
Can J Cardiol; 2019 Jul; 35(7):884-891. PubMed ID: 31292087
[TBL] [Abstract][Full Text] [Related]
15. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
[TBL] [Abstract][Full Text] [Related]
16. Risk of Incident Atherosclerotic Cardiovascular DiseaseEvents by Achieved Atherogenic Lipid Levels Among62,428 Statin-Treated Individuals With Diabetes Mellitus.
Rana JS; Liu JY; Moffet HH; Boklage SH; Khan I; Karter AJ
Am J Cardiol; 2018 Sep; 122(5):762-767. PubMed ID: 30057224
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic cardiovascular disease risk and small dense low-density lipoprotein cholesterol in men, women, African Americans and non-African Americans: The pooling project.
Schaefer EJ; Ikezaki H; Diffenderfer MR; Lim E; Liu CT; Hoogeveen RC; Guan W; Tsai MY; Ballantyne CM
Atherosclerosis; 2023 Feb; 367():15-23. PubMed ID: 36724690
[TBL] [Abstract][Full Text] [Related]
18. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
Delialis D; Georgiopoulos G; Aivalioti E; Mavraganis G; Dimopoulou AM; Sianis A; Aggelidakis L; Patras R; Petropoulos I; Ioannou S; Syrigou R; Chatzidou S; Kanakakis I; Stellos K; Stamatelopoulos K
Hellenic J Cardiol; 2022; 66():26-31. PubMed ID: 35667617
[TBL] [Abstract][Full Text] [Related]
19. Population health management of low-density lipoprotein cholesterol via a remote, algorithmic, navigator-executed program.
Plutzky J; Benson MD; Chaney K; Bui TV; Kraft M; Matta L; McPartlin M; Zelle D; Cannon CP; Dodek A; Gaziano TA; Desai AS; MacRae CA; Scirica BM
Am Heart J; 2022 Jan; 243():15-27. PubMed ID: 34481756
[TBL] [Abstract][Full Text] [Related]
20. Inverted U-Shaped Association of Plasma Resolvin D2 With Atherosclerotic Cardiovascular Disease and the Mediation Effects of Serum Cholesterol: A Chinese Community-Based Study.
Liu B; Zhang J; Zhang K; Li M; Jing Y; Gu S; Ding H; Liang Y; Zhou H; Dong C
J Am Heart Assoc; 2024 Mar; 13(5):e032588. PubMed ID: 38420767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
